Home/Filings/4/0001104659-22-045488
4//SEC Filing

Bashan Dror 4

Accession 0001104659-22-045488

CIK 0001006281other

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 4:05 PM ET

Size

6.0 KB

Accession

0001104659-22-045488

Insider Transaction Report

Form 4
Period: 2022-04-11
Bashan Dror
DirectorPRESIDENT AND CEO
Transactions
  • Purchase

    Common Stock

    2022-04-11$1.50/sh+68,000$102,00068,000 total
Holdings
  • Common Stock

    (indirect: By Trust)
    1,085,458
Footnotes (2)
  • [F1]The reporting person holds the shares in an account with his spouse as joint tenants.
  • [F2]Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the employee under its Amended and Restated 2006 Stock Incentive Plan, as amended June 7, 2020. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.

Issuer

Protalix BioTherapeutics, Inc.

CIK 0001006281

Entity typeother

Related Parties

1
  • filerCIK 0001781450

Filing Metadata

Form type
4
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 4:05 PM ET
Size
6.0 KB